New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, including Roctavian, BioMarin’s gene therapy for severe hemophilia A.
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, including Roctavian, BioMarin’s gene therapy for severe hemophilia A.